Related Experiment Video
Updated: Aug 22, 2025

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Neurofibromatosis Type 1: Diagnostic Timelines in Children.
F J García-Martínez1, A Hernández-Martín2
1Departamento de Dermatología, Clínica Universidad de Navarra, Madrid, España.
Diagnosing neurofibromatosis 1 (NF1) in children without a family history is delayed by nearly four years. Early identification of NF1 relies on skin manifestations like café au lait spots.
Area of Science:
- Genetics
- Pediatrics
- Dermatology
Background:
- Diagnosing neurofibromatosis 1 (NF1) in young children, especially those without a known family history, presents significant challenges.
- NF1 diagnosis relies on specific clinical criteria, which can be difficult to meet in early childhood.
Purpose of the Study:
- To determine the diagnostic delay for NF1 in children lacking a family history.
- To evaluate the utility of café au lait macules and skin fold freckling as early diagnostic indicators for NF1.
Main Methods:
- A retrospective, observational study reviewed 108 pediatric NF1 patients.
- Patients were grouped based on the presence or absence of a known parental NF1 history.
- Café au lait macules and skin fold freckling were assessed as potential single diagnostic criteria.
Main Results:
- The average age of NF1 diagnosis was 3.94 years overall.
- Children with a parental history were diagnosed at 1 year, while those without were diagnosed at 4 years and 8 months.
- This indicates a diagnostic delay of approximately 3 years and 8 months for children without a family history.
Conclusions:
- Skin lesions, such as café au lait macules, are often the initial sign of NF1.
- The current diagnostic criteria for NF1 may require updates to improve early detection in pediatric populations.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023